Paediatric HIV top priority says leading AIDS researcher

A well-known AIDS researcher, Dr. Julio Montaner, affirms the goal of Caritas Internationalis “HAART for Children Campaign,” which began in 2009 to promote early diagnosis and treatment of mothers and children living with HIV infection

Dr. Julio Montaner is the director of the Saint Paul’s Hospital/British Columbia Centre for Excellence in HIV/AIDS. Although he has concentrated most of his research and clinical practice on adults with HIV, he pioneered universal access to life-saving Highly Active Anti-Retroviral Treatment (HAART) for all people living with HIV, no matter how recent or advanced their infection might be.

Dr. Montaner served as the inspiration for Caritas’ own “HAART for Children” campaign. He said that “the only way to begin to conceive an end to this pandemic is if we ensure that there is global, universal access to antiretroviral therapy and related services.” Dr. Montaner spoke with Francesca Merico, volunteer Coordinator of the Caritas “HAART for Children Campaign” for the latest, July 2015 issue of the Campaign Newsletter. He further affirmed,”There should be no doubt in our mind that paediatric HIV should be a top priority.”

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below